TITLE

Prediction of event times in the REMATCH Trial

AUTHOR(S)
Ying, Gui-Shuang; Heitjan, Daniel F
PUB. DATE
April 2013
SOURCE
Clinical Trials;Apr2013, Vol. 10 Issue 2, p197
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
86418583

 

Related Articles

  • Death on an LVAD—Two Sides of a Coin. Phan, Justin A.K.; Muthiah, Kavitha; Robson, Desiree; Macdonald, Peter S.; Keogh, Anne M.; Kotlyar, Eugene; Spratt, Phillip; Dhital, Kumud; Granger, Emily; Jansz, Paul; Hayward, Christopher S. // Heart, Lung & Circulation;Nov2013, Vol. 22 Issue 11, p952 

    LVADs are increasingly being used to support patients with end stage heart failure. As such, the traditional definition of death, the absence of a pulse, requires re-examination as it is no longer clinically relevant. We present two contrasting cases of “death” on LVAD support and...

  • Biventricular Assist Devices: A Technical Review. Gregory, Shaun; Timms, Daniel; Gaddum, Nicholas; Mason, David; Fraser, John // Annals of Biomedical Engineering;Sep2011, Vol. 39 Issue 9, p2313 

    The optimal treatment option for end stage heart failure is transplantation; however, the shortage of donor organs necessitates alternative treatment strategies such as mechanical circulatory assistance. Ventricular assist devices (VADs) are employed to support these cases while awaiting cardiac...

  • Results of medium-term survival in patients undergoing cardiac transplantation: institutional experience. Custódio, Ires Lopes; Teixeira Lima, Francisca Elisângela; de Oliveira Lopes, Marcos Venícios; da Silva, Viviane Martins; Santos Neto, João David; do Perpétuo Socorro Martins, Maria; de Oliveira, Samya Coutinho // Brazilian Journal of Cardiovascular Surgery;Oct-Dec2013, Vol. 28 Issue 4, p470 

    Introduction: The heart transplant became a consecrated therapy for patients with terminal heart failure, increasingly improving the survival. Objective: To identify the medium-term results in patients undergoing cardiac transplantation. Methods: This is a descriptive, documentary and...

  • Cannulation techniques for temporary right and left ventricular support: simple solutions for a difficult problem. De Silva, Ravi J.; Gallo, Alina; Westaby, Stephen // European Journal of Cardio-Thoracic Surgery;Oct2012, Vol. 42 Issue 4, p728 

    End-stage cardiac failure where appropriate is best treated with cardiac transplantation. With improvements in medical therapy, the emergence of primary percutaneous coronary intervention, and an increasingly ageing population, patients with right, left or biventricular failure, who are not...

  • CentriMag® short-term ventricular assist as a bridge to solution in patients with advanced heart failure: use beyond 30 days†. Mohite, Prashant N.; Zych, Bartlomiej; Popov, Aron F.; Sabashnikov, Anton; Sáez, Diana G.; Patil, Nikhil P.; Amrani, Mohamed; Bahrami, Toufan; DeRobertis, Fabio; Maunz, Olaf; Marczin, Nandor; Banner, Nicholas R.; Simon, Andre R. // European Journal of Cardio-Thoracic Surgery;Nov2013, Vol. 44 Issue 5, pe310 

    OBJECTIVES Left ventricular assist devices (LVADs) offer very valuable therapeutic options for patients with advanced heart failure. CentriMag® (Thoratec, Pleasanton, CA, USA) is an extracorporeal short-term circulatory assist device Conformité Européenne-marked in Europe for use up to...

  • Case Report of a Patient with Left Ventricular Assistance Device Undergoing Chemotherapy for a New Diagnosis of Lung Cancer. Khan, Maliha; Wasim, Anum; Mirrakhimov, Aibek E.; McMahon, Blaithin A.; Judge, Daniel P.; Chu, Linda C.; Banavali, Ashtami; Zeidan, Amer M. // Case Reports in Oncological Medicine;3/22/2015, Vol. 2015, p1 

    The optimal management of cancer in patients with severe heart failure is not defined. This issue is particularly challenging when a diagnosis of limited-stage small cell lung cancer (SCLC) is made incidentally in the context of evaluating patient for candidacy for cardiac transplantation....

  • Focused Review on Transthoracic Echocardiographic Assessment of Patients with Continuous Axial Left Ventricular Assist Devices. Topilsky, Yan; Maltais, Simon; Oh, Jae K.; Atchison, Fawn W.; Perrault, Louis P.; Carrier, Michel; Park, Soon J. // Cardiology Research & Practice;2011, p1 

    Left ventricular assist devices (LVADs) are systems for mechanical support for patients with end-stage heart failure. Preoperative, postoperative and comprehensive followup with transthoracic echocardiography has a major role in LVAD patient management. In this paper, we will present briefly the...

  • Building a bridge to recovery: the pathophysiology of LVAD-induced reverse modeling in heart failure. Miyagawa, Shigeru; Toda, Koichi; Nakamura, Teruya; Yoshikawa, Yasushi; Fukushima, Satsuki; Saito, Shunsuke; Yoshioka, Daisuke; Saito, Tetsuya; Sawa, Yoshiki // Surgery Today;Feb2016, Vol. 46 Issue 2, p149 

    Heart failure mainly caused by ischemic or dilated cardiomyopathy is a life-threatening disorder worldwide. The previous work in cardiac surgery has led to many excellent surgical techniques for treating cardiac diseases, and these procedures are now able to prolong the human lifespan. However,...

  • Simulation of Dilated Heart Failure with Continuous Flow Circulatory Support. Wang, Yajuan; Loghmanpour, Natasha; Vandenberghe, Stijn; Ferreira, Antonio; Keller, Bradley; Gorcsan, John; Antaki, James // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Lumped parameter models have been employed for decades to simulate important hemodynamic couplings between a left ventricular assist device (LVAD) and the native circulation. However, these studies seldom consider the pathological descending limb of the Frank-Starling response of the overloaded...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics